STRUCTURAL REQUIREMENTS OF THE CYTOPLASMIC DOMAINS OF THE HUMAN MACROPHAGE FC-GAMMA RECEPTOR-IIA AND B-CELL FC-GAMMA RECEPTOR-IIB2 FOR THE ENDOCYTOSIS OF IMMUNE-COMPLEXES
ENGELHARDT W, GORCZYTZA H, BUTTERWECK A, MONKEMANN H, Frey J (1991)
EUROPEAN JOURNAL OF IMMUNOLOGY 21(9): 2227-2238.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
ENGELHARDT, W;
GORCZYTZA, H;
BUTTERWECK, A;
MONKEMANN, H;
Frey, JürgenUniBi
Einrichtung
Abstract / Bemerkung
Two isotypes of the monocyte/macrophage as well as B cell Fc-gamma receptor type II (FcRIIa and FcRIIb2, respectively) mainly differ in the length (76 vs. 44 amino acids) and amino acid sequence of their cytoplasmic domains. Only the eight amino acids just behind the putative transmembrane region are identical. Despite this marked difference, both FcRII mediate endocytosis of immune complexes. To determine the functional significance of the cytoplasmic domains, we expressed truncated FcRIIa and FcRIIb2 in FcR- BHK-21 cells. Mutants of both receptors containing only one amino acid (tail-minus) of the cytoplasmic domain failed to mediate immune complex uptake. The significance of the cytoplasmic domain of the receptors could be further demonstrated using a chimeric FcRIII-FcRIIa construct. Therefore we expressed an FcRIII lacking the hydrophobic carboxyl terminus (containing the putative phosphatidyl - inositol - glycan anchor site) fused inframe to the transmembrane and cytoplasmic domain of the FcRIIa in BHK-21 cells. In contrast to the wild type FcRIII, this chimeric receptor mediated immune complex uptake indistinguishable from that mediated by the FcRIIa. Receptor mutants with relatively short cytoplasmic domains (FcRIIb2: 13, and FcRIIa: 16 amino acids) revealed, that these short amino acid stretches are sufficient to allow reduced receptor-mediated endocytosis of bound ligand. Furthermore, using FcRIIa deletion mutants with a cytoplasmic domain consisting of 62, 46, and 28 amino acids, respectively, we found that the capability of these mutants to mediate immune complex uptake decreased gradually with the truncation of the cytoplasmic tails. Thus, only short amino acids sequences of the cytoplasmic domain are sufficient to enable an, albeit reduced, receptor-mediated endocytosis.
Erscheinungsjahr
1991
Zeitschriftentitel
EUROPEAN JOURNAL OF IMMUNOLOGY
Band
21
Ausgabe
9
Seite(n)
2227-2238
ISSN
0014-2980
eISSN
1521-4141
Page URI
https://pub.uni-bielefeld.de/record/1649368
Zitieren
ENGELHARDT W, GORCZYTZA H, BUTTERWECK A, MONKEMANN H, Frey J. STRUCTURAL REQUIREMENTS OF THE CYTOPLASMIC DOMAINS OF THE HUMAN MACROPHAGE FC-GAMMA RECEPTOR-IIA AND B-CELL FC-GAMMA RECEPTOR-IIB2 FOR THE ENDOCYTOSIS OF IMMUNE-COMPLEXES. EUROPEAN JOURNAL OF IMMUNOLOGY. 1991;21(9):2227-2238.
ENGELHARDT, W., GORCZYTZA, H., BUTTERWECK, A., MONKEMANN, H., & Frey, J. (1991). STRUCTURAL REQUIREMENTS OF THE CYTOPLASMIC DOMAINS OF THE HUMAN MACROPHAGE FC-GAMMA RECEPTOR-IIA AND B-CELL FC-GAMMA RECEPTOR-IIB2 FOR THE ENDOCYTOSIS OF IMMUNE-COMPLEXES. EUROPEAN JOURNAL OF IMMUNOLOGY, 21(9), 2227-2238. https://doi.org/10.1002/eji.1830210934
ENGELHARDT, W, GORCZYTZA, H, BUTTERWECK, A, MONKEMANN, H, and Frey, Jürgen. 1991. “STRUCTURAL REQUIREMENTS OF THE CYTOPLASMIC DOMAINS OF THE HUMAN MACROPHAGE FC-GAMMA RECEPTOR-IIA AND B-CELL FC-GAMMA RECEPTOR-IIB2 FOR THE ENDOCYTOSIS OF IMMUNE-COMPLEXES”. EUROPEAN JOURNAL OF IMMUNOLOGY 21 (9): 2227-2238.
ENGELHARDT, W., GORCZYTZA, H., BUTTERWECK, A., MONKEMANN, H., and Frey, J. (1991). STRUCTURAL REQUIREMENTS OF THE CYTOPLASMIC DOMAINS OF THE HUMAN MACROPHAGE FC-GAMMA RECEPTOR-IIA AND B-CELL FC-GAMMA RECEPTOR-IIB2 FOR THE ENDOCYTOSIS OF IMMUNE-COMPLEXES. EUROPEAN JOURNAL OF IMMUNOLOGY 21, 2227-2238.
ENGELHARDT, W., et al., 1991. STRUCTURAL REQUIREMENTS OF THE CYTOPLASMIC DOMAINS OF THE HUMAN MACROPHAGE FC-GAMMA RECEPTOR-IIA AND B-CELL FC-GAMMA RECEPTOR-IIB2 FOR THE ENDOCYTOSIS OF IMMUNE-COMPLEXES. EUROPEAN JOURNAL OF IMMUNOLOGY, 21(9), p 2227-2238.
W. ENGELHARDT, et al., “STRUCTURAL REQUIREMENTS OF THE CYTOPLASMIC DOMAINS OF THE HUMAN MACROPHAGE FC-GAMMA RECEPTOR-IIA AND B-CELL FC-GAMMA RECEPTOR-IIB2 FOR THE ENDOCYTOSIS OF IMMUNE-COMPLEXES”, EUROPEAN JOURNAL OF IMMUNOLOGY, vol. 21, 1991, pp. 2227-2238.
ENGELHARDT, W., GORCZYTZA, H., BUTTERWECK, A., MONKEMANN, H., Frey, J.: STRUCTURAL REQUIREMENTS OF THE CYTOPLASMIC DOMAINS OF THE HUMAN MACROPHAGE FC-GAMMA RECEPTOR-IIA AND B-CELL FC-GAMMA RECEPTOR-IIB2 FOR THE ENDOCYTOSIS OF IMMUNE-COMPLEXES. EUROPEAN JOURNAL OF IMMUNOLOGY. 21, 2227-2238 (1991).
ENGELHARDT, W, GORCZYTZA, H, BUTTERWECK, A, MONKEMANN, H, and Frey, Jürgen. “STRUCTURAL REQUIREMENTS OF THE CYTOPLASMIC DOMAINS OF THE HUMAN MACROPHAGE FC-GAMMA RECEPTOR-IIA AND B-CELL FC-GAMMA RECEPTOR-IIB2 FOR THE ENDOCYTOSIS OF IMMUNE-COMPLEXES”. EUROPEAN JOURNAL OF IMMUNOLOGY 21.9 (1991): 2227-2238.
Daten bereitgestellt von European Bioinformatics Institute (EBI)
10 Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
Biotechnological approaches for the production of prebiotics and their potential applications.
Panesar PS, Kumari S, Panesar R., Crit. Rev. Biotechnol. 33(4), 2013
PMID: 22985065
Panesar PS, Kumari S, Panesar R., Crit. Rev. Biotechnol. 33(4), 2013
PMID: 22985065
Differential requirement of lipid rafts for FcγRIIA mediated effector activities.
Vieth JA, Kim MK, Pan XQ, Schreiber AD, Worth RG., Cell. Immunol. 265(2), 2010
PMID: 20728077
Vieth JA, Kim MK, Pan XQ, Schreiber AD, Worth RG., Cell. Immunol. 265(2), 2010
PMID: 20728077
The inhibitory receptor FcgammaRII reduces joint inflammation and destruction in experimental immune complex-mediated arthritides not only by inhibition of FcgammaRI/III but also by efficient clearance and endocytosis of immune complexes.
van Lent P, Nabbe KC, Boross P, Blom AB, Roth J, Holthuysen A, Sloetjes A, Verbeek S, van den Berg W., Am. J. Pathol. 163(5), 2003
PMID: 14578184
van Lent P, Nabbe KC, Boross P, Blom AB, Roth J, Holthuysen A, Sloetjes A, Verbeek S, van den Berg W., Am. J. Pathol. 163(5), 2003
PMID: 14578184
Design, synthesis, expression, and characterization of the genes for mouse Fc gamma RIIb1 and Fc gamma RIIb2 cytoplasmic regions.
Chen L, Thompson NL, Pielak GJ., Protein Sci. 6(5), 1997
PMID: 9144775
Chen L, Thompson NL, Pielak GJ., Protein Sci. 6(5), 1997
PMID: 9144775
Epitope mapping of new monoclonal antibodies recognizing distinct human FcRII (CD32) isoforms.
Weinrich V, Sondermann P, Bewarder N, Wissel K, Frey J., Hybridoma 15(2), 1996
PMID: 8743290
Weinrich V, Sondermann P, Bewarder N, Wissel K, Frey J., Hybridoma 15(2), 1996
PMID: 8743290
In vivo and in vitro specificity of protein tyrosine kinases for immunoglobulin G receptor (FcgammaRII) phosphorylation.
Bewarder N, Weinrich V, Budde P, Hartmann D, Flaswinkel H, Reth M, Frey J., Mol. Cell. Biol. 16(9), 1996
PMID: 8756631
Bewarder N, Weinrich V, Budde P, Hartmann D, Flaswinkel H, Reth M, Frey J., Mol. Cell. Biol. 16(9), 1996
PMID: 8756631
Structure/function relationships of Fc gamma receptors in phagocytosis.
Indik ZK, Park JG, Hunter S, Schreiber AD., Semin. Immunol. 7(1), 1995
PMID: 7612895
Indik ZK, Park JG, Hunter S, Schreiber AD., Semin. Immunol. 7(1), 1995
PMID: 7612895
Fc receptor-mediated signal transduction.
Lin CT, Shen Z, Boros P, Unkeless JC., J. Clin. Immunol. 14(1), 1994
PMID: 8132732
Lin CT, Shen Z, Boros P, Unkeless JC., J. Clin. Immunol. 14(1), 1994
PMID: 8132732
The disulfide bridges of the immunoglobulin-like domains of Fc gamma RIIIB are essential for efficient expression and biological activity.
Enenkel B, Frey J., J. Protein Chem. 12(4), 1993
PMID: 8251066
Enenkel B, Frey J., J. Protein Chem. 12(4), 1993
PMID: 8251066
Lineage-independent activation of immune system effector function by myeloid Fc receptors.
Kolanus W, Romeo C, Seed B., EMBO J. 11(13), 1992
PMID: 1464313
Kolanus W, Romeo C, Seed B., EMBO J. 11(13), 1992
PMID: 1464313
40 References
Daten bereitgestellt von Europe PubMed Central.
Membrane anchoring and spontaneous release of CD16 (FcR III) by natural killer cells and granulocytes.
Lanier LL, Phillips JH, Testi R., Eur. J. Immunol. 19(4), 1989
PMID: 2525100
Lanier LL, Phillips JH, Testi R., Eur. J. Immunol. 19(4), 1989
PMID: 2525100
The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies.
Perussia B, Trinchieri G, Jackson A, Warner NL, Faust J, Rumpold H, Kraft D, Lanier LL., J. Immunol. 133(1), 1984
PMID: 6233371
Perussia B, Trinchieri G, Jackson A, Warner NL, Faust J, Rumpold H, Kraft D, Lanier LL., J. Immunol. 133(1), 1984
PMID: 6233371
NKP-15: a monoclonal antibody reactive against purified human natural killer cells and granulocytes.
Phillips JH, Babcock GF., Immunol. Lett. 6(3), 1983
PMID: 6862527
Phillips JH, Babcock GF., Immunol. Lett. 6(3), 1983
PMID: 6862527
Pearse, Trends Biochem. Sci. 5(), 1980
Höning, 0
Transport of macrophage Fc receptors and Fc receptor-bound ligands to lysosomes.
Ukkonen P, Lewis V, Marsh M, Helenius A, Mellman I., J. Exp. Med. 163(4), 1986
PMID: 3950548
Ukkonen P, Lewis V, Marsh M, Helenius A, Mellman I., J. Exp. Med. 163(4), 1986
PMID: 3950548
Sinclair, Immunol. Today 8(), 1987
Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions.
Ravetch JV, Perussia B., J. Exp. Med. 170(2), 1989
PMID: 2526846
Ravetch JV, Perussia B., J. Exp. Med. 170(2), 1989
PMID: 2526846
Fc receptor isoforms exhibit distinct abilities for coated pit localization as a result of cytoplasmic domain heterogeneity.
Miettinen HM, Rose JK, Mellman I., Cell 58(2), 1989
PMID: 2568890
Miettinen HM, Rose JK, Mellman I., Cell 58(2), 1989
PMID: 2568890
Davis, J. Biol. Chem. 262(), 1987
Deletion of the cytoplasmic domain of the polymeric immunoglobulin receptor prevents basolateral localization and endocytosis.
Mostov KE, de Bruyn Kops A, Deitcher DL., Cell 47(3), 1986
PMID: 3768957
Mostov KE, de Bruyn Kops A, Deitcher DL., Cell 47(3), 1986
PMID: 3768957
Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4.
Bedinger P, Moriarty A, von Borstel RC 2nd, Donovan NJ, Steimer KS, Littman DR., Nature 334(6178), 1988
PMID: 3260353
Bedinger P, Moriarty A, von Borstel RC 2nd, Donovan NJ, Steimer KS, Littman DR., Nature 334(6178), 1988
PMID: 3260353
Requirements for modulation of the CD4 molecule in response to phorbol myristate acetate. Role of the cytoplasmic domain.
Sleckman BP, Bigby M, Greenstein JL, Burakoff SJ, Sy MS., J. Immunol. 142(5), 1989
PMID: 2783943
Sleckman BP, Bigby M, Greenstein JL, Burakoff SJ, Sy MS., J. Immunol. 142(5), 1989
PMID: 2783943
Structural features of the cytoplasmic region of CD4 required for internalization.
Shin J, Doyle C, Yang Z, Kappes D, Strominger JL., EMBO J. 9(2), 1990
PMID: 2105883
Shin J, Doyle C, Yang Z, Kappes D, Strominger JL., EMBO J. 9(2), 1990
PMID: 2105883
Fc receptor phosphorylation during receptor-mediated control of B-cell activation.
Hunziker W, Koch T, Whitney JA, Mellman I., Nature 345(6276), 1990
PMID: 2190097
Hunziker W, Koch T, Whitney JA, Mellman I., Nature 345(6276), 1990
PMID: 2190097
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 1832386
PubMed | Europe PMC
Suchen in